NCT00230308

Brief Summary

Through this study, we hope to learn more about the mechanisms, which may contribute to development and progression of head and neck cancer. The long-term goal of this study will be to develop new strategies and drugs for the diagnosis and treatment of head and neck cancer.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
56mo left

Started Apr 2002

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Apr 2002Dec 2030

Study Start

First participant enrolled

April 2, 2002

Completed
3.5 years until next milestone

First Submitted

Initial submission to the registry

September 28, 2005

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 30, 2005

Completed
24.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2030

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2030

Last Updated

December 24, 2025

Status Verified

December 1, 2025

Enrollment Period

28.2 years

First QC Date

September 28, 2005

Last Update Submit

December 22, 2025

Conditions

Head and Neck Cancer

Keywords

Head and Neck Cancer

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients undergoing surgery at Stanford University for head and neck cancer.

You may qualify if:

  • All patients undergoing surgery at Stanford University for head and neck cancer.

You may not qualify if:

  • Non-Stanford patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University School of Medicine

Stanford, California, 94305, United States

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

At the time of biospy or surgery, a small amount of tumor tissue (approximately 1 cc) will be taken from the main tumor specimen and stored until analysis.

MeSH Terms

Conditions

Head and Neck Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasms

Study Officials

  • John B Sunwoo

    Stanford University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nikita Bedi

CONTACT

650-723-5957nbedi@stanford.edu

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 28, 2005

First Posted

September 30, 2005

Study Start

April 2, 2002

Primary Completion (Estimated)

June 1, 2030

Study Completion (Estimated)

December 1, 2030

Last Updated

December 24, 2025

Record last verified: 2025-12

Locations

US(1)